Literature DB >> 2104235

Fate of injected interleukin 1 in rats: sequestration and degradation in the kidney.

S Poole1, T A Bird, S Selkirk, R E Gaines-Das, Y Choudry, S L Stephenson, A J Kenny, J Saklatvaa.   

Abstract

The tissue distribution and route of clearance of human recombinant interleukin 1 alpha (IL 1 alpha) injected intravenously in rats was studied. The plasma half-life was approximately 2.5 min, and this was increased after nephrectomy, the kidney being the major organ through which the IL 1 alpha was excreted. Two iodinated fragments of IL 1 alpha, of approximately 5 and 9 kDa, were excreted by the kidneys whereas only intact, 17-kDa IL 1 alpha was detected in plasma, suggesting that the protein was being degraded after uptake by the kidney. The results of in vivo experiments in which surface endopeptidase-24.11 was inhibited with phosphoramidon and in vitro experiments in which rat kidney homogenates were incubated with radiolabeled IL 1 alpha suggest that the cytokine was endocytosed and then hydrolysed by lysosomal proteinases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104235     DOI: 10.1016/1043-4666(90)90050-4

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  15 in total

Review 1.  Incremental dialysis for preserving residual kidney function-Does one size fit all when initiating dialysis?

Authors:  Anna T Mathew; Yoshitsugu Obi; Connie M Rhee; Jason A Chou; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2018-05-07       Impact factor: 3.455

2.  Hydrolysis of transforming growth factor-alpha by cell-surface peptidases in vitro.

Authors:  Y Choudry; A J Kenny
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

3.  C reactive protein and long-term risk for chronic kidney disease: a historical prospective study.

Authors:  Eitan Kugler; Eytan Cohen; Elad Goldberg; Yuval Nardi; Amos Levi; Irit Krause; Moshe Garty; Ilan Krause
Journal:  J Nephrol       Date:  2014-07-01       Impact factor: 3.902

Review 4.  Inflammation and cachexia in chronic kidney disease.

Authors:  Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-01-29       Impact factor: 3.714

Review 5.  Hepcidin in anemia of chronic kidney disease: review for the pediatric nephrologist.

Authors:  Meredith A Atkinson; Colin T White
Journal:  Pediatr Nephrol       Date:  2011-03-13       Impact factor: 3.714

Review 6.  Chronic kidney disease and inflammation in pediatric patients: from bench to playground.

Authors:  Roberto Pecoits-Filho; Lucimary C Sylvestre; Peter Stenvinkel
Journal:  Pediatr Nephrol       Date:  2005-04-26       Impact factor: 3.714

Review 7.  Preservation of residual kidney function in hemodialysis patients: reviving an old concept.

Authors:  Anna T Mathew; Steven Fishbane; Yoshitsugu Obi; Kamyar Kalantar-Zadeh
Journal:  Kidney Int       Date:  2016-05-12       Impact factor: 10.612

8.  Malnutrition-inflammation-atherosclerosis syndrome in Chronic Kidney disease.

Authors:  Pragna Rao; G C Reddy; A S Kanagasabapathy
Journal:  Indian J Clin Biochem       Date:  2008-10-01

9.  Evaluation of bioartificial renal tubule device prepared with human renal proximal tubular epithelial cells cultured in serum-free medium.

Authors:  Hiroo Takahashi; Kaichiro Sawada; Takatoshi Kakuta; Takao Suga; Kazuya Hanai; Genta Kanai; Satoshi Fujimura; Noriyuki Sanechika; Toshiro Terachi; Masafumi Fukagawa; Akira Saito
Journal:  J Artif Organs       Date:  2013-05-12       Impact factor: 1.731

Review 10.  Mechanisms of haemolysis-induced kidney injury.

Authors:  Kristof Van Avondt; Erfan Nur; Sacha Zeerleder
Journal:  Nat Rev Nephrol       Date:  2019-08-27       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.